APA (7th ed.) Citation

J, P., M, d. l. H., B, B., I, d. J., X, M., C, L., . . . JC, C. (2020). Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH). Virchows Archiv : an international journal of pathology, 476(2), 195. https://doi.org/10.1007/s00428-019-02709-3

Chicago Style (17th ed.) Citation

J, Palacios, et al. "Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH)." Virchows Archiv : An International Journal of Pathology 476, no. 2 (2020): 195. https://doi.org/10.1007/s00428-019-02709-3.

MLA (9th ed.) Citation

J, Palacios, et al. "Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH)." Virchows Archiv : An International Journal of Pathology, vol. 476, no. 2, 2020, p. 195, https://doi.org/10.1007/s00428-019-02709-3.